These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 33830330)

  • 1. Tau strains shape disease.
    Vaquer-Alicea J; Diamond MI; Joachimiak LA
    Acta Neuropathol; 2021 Jul; 142(1):57-71. PubMed ID: 33830330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain.
    Narasimhan S; Guo JL; Changolkar L; Stieber A; McBride JD; Silva LV; He Z; Zhang B; Gathagan RJ; Trojanowski JQ; Lee VMY
    J Neurosci; 2017 Nov; 37(47):11406-11423. PubMed ID: 29054878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.
    Tarutani A; Miyata H; Nonaka T; Hasegawa K; Yoshida M; Saito Y; Murayama S; Robinson AC; Mann DMA; Tomita T; Hasegawa M
    Brain; 2021 Sep; 144(8):2333-2348. PubMed ID: 33693528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Travels with tau prions.
    Diamond MI
    Cytoskeleton (Hoboken); 2024 Jan; 81(1):83-88. PubMed ID: 37950616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invited review: Neuropathology of tauopathies: principles and practice.
    Kovacs GG
    Neuropathol Appl Neurobiol; 2015 Feb; 41(1):3-23. PubMed ID: 25495175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct phosphorylation profiles of tau in brains of patients with different tauopathies.
    Samimi N; Sharma G; Kimura T; Matsubara T; Huo A; Chiba K; Saito Y; Murayama S; Akatsu H; Hashizume Y; Hasegawa M; Farjam M; Shahpasand K; Ando K; Hisanaga SI
    Neurobiol Aging; 2021 Dec; 108():72-79. PubMed ID: 34536819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct tau prion strains propagate in cells and mice and define different tauopathies.
    Sanders DW; Kaufman SK; DeVos SL; Sharma AM; Mirbaha H; Li A; Barker SJ; Foley AC; Thorpe JR; Serpell LC; Miller TM; Grinberg LT; Seeley WW; Diamond MI
    Neuron; 2014 Jun; 82(6):1271-88. PubMed ID: 24857020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based classification of tauopathies.
    Shi Y; Zhang W; Yang Y; Murzin AG; Falcon B; Kotecha A; van Beers M; Tarutani A; Kametani F; Garringer HJ; Vidal R; Hallinan GI; Lashley T; Saito Y; Murayama S; Yoshida M; Tanaka H; Kakita A; Ikeuchi T; Robinson AC; Mann DMA; Kovacs GG; Revesz T; Ghetti B; Hasegawa M; Goedert M; Scheres SHW
    Nature; 2021 Oct; 598(7880):359-363. PubMed ID: 34588692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau prions from Alzheimer's disease and chronic traumatic encephalopathy patients propagate in cultured cells.
    Woerman AL; Aoyagi A; Patel S; Kazmi SA; Lobach I; Grinberg LT; McKee AC; Seeley WW; Olson SH; Prusiner SB
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8187-E8196. PubMed ID: 27911827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuropathology of tauopathy].
    Yoshida M
    Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion-like Spreading in Tauopathies.
    Ayers JI; Giasson BI; Borchelt DR
    Biol Psychiatry; 2018 Feb; 83(4):337-346. PubMed ID: 28506438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau monomer encodes strains.
    Sharma AM; Thomas TL; Woodard DR; Kashmer OM; Diamond MI
    Elife; 2018 Dec; 7():. PubMed ID: 30526844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local structural preferences in shaping tau amyloid polymorphism.
    Louros N; Wilkinson M; Tsaka G; Ramakers M; Morelli C; Garcia T; Gallardo R; D'Haeyer S; Goossens V; Audenaert D; Thal DR; Mackenzie IR; Rademakers R; Ranson NA; Radford SE; Rousseau F; Schymkowitz J
    Nat Commun; 2024 Feb; 15(1):1028. PubMed ID: 38310108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
    Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review.
    Gibbons GS; Lee VMY; Trojanowski JQ
    JAMA Neurol; 2019 Jan; 76(1):101-108. PubMed ID: 30193298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms.
    Tolnay M; Sergeant N; Ghestem A; Chalbot S; De Vos RA; Jansen Steur EN; Probst A; Delacourte A
    Acta Neuropathol; 2002 Oct; 104(4):425-34. PubMed ID: 12200631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo.
    Kaufman SK; Sanders DW; Thomas TL; Ruchinskas AJ; Vaquer-Alicea J; Sharma AM; Miller TM; Diamond MI
    Neuron; 2016 Nov; 92(4):796-812. PubMed ID: 27974162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations causing neurodegenerative tauopathies.
    Goedert M; Jakes R
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):240-50. PubMed ID: 15615642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tauopathies as clinicopathological entities.
    Irwin DJ
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S29-33. PubMed ID: 26382841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.